Roche
Search results
Lonza Singapore Tuas offers cGMP manufacturing and development services for monoclonal antibodies, recombinant proteins and allogeneic cell therapy products. The site is part of Lonza's global network and has a track record of successful inspections and quality standards.
4 days ago · Find your job opportunity at Lonza and become part of our global teams. Submit your application now and get one step closer to making a meaningful... Learn more
Lonza is a Swiss-based company that operates in four divisions: Biologics, Small Molecules, Cell & Gene and Capsules & Health Ingredients. It has a secondary listing on the SGX Singapore Exchange and generates sales of CHF 6.7 billion.
Oct 11, 2021 · Lonza is investing to expand mammalian development services at its Singapore facility; the move will bring additional capacity for cell culture, purification, and analytical services for mammalian biologics.
Lonza is a global partner to the pharmaceutical, biotech, and nutrition markets, offering services and products from early phase discovery to custom development and manufacturing. Learn about their facility in Tuas Biomedical Park, Singapore, and their internship program for life science students.
Oct 7, 2021 · Lonza invests in a new lab and upgrades existing facilities to offer cell line construction, process development, and characterization services for biologics and cell therapy. The expansion aims to support the growing market for complex protein formats and regulatory approvals.
Lonza is a global pharmaceutical manufacturing company with a site in Singapore. Learn about its products, services, employees, webinars and events on LinkedIn.
